Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 4
2003 3
2004 2
2005 4
2006 9
2007 6
2008 9
2009 7
2010 13
2011 29
2012 30
2013 20
2014 34
2015 50
2016 36
2017 42
2018 44
2019 49
2020 45
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

407 results
Results by year
Filters applied: . Clear all
Page 1
The Role of Vitamin E in the Treatment of NAFLD.
Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Perumpail BJ, et al. Diseases. 2018 Sep 24;6(4):86. doi: 10.3390/diseases6040086. Diseases. 2018. PMID: 30249972 Free PMC article. Review.
There has been a growing interest in the role of vitamin E supplementation in the treatment and/or prevention of nonalcoholic fatty liver (NAFLD). ...Current guidelines regarding the use of vitamin E in the setting of NAFLD
There has been a growing interest in the role of vitamin E supplementation in the treatment and/or prevention of nonalcoholic …
Role of vitamin E in nonalcoholic fatty liver disease.
Nagashimada M, Ota T. Nagashimada M, et al. IUBMB Life. 2019 Apr;71(4):516-522. doi: 10.1002/iub.1991. Epub 2018 Dec 27. IUBMB Life. 2019. PMID: 30592129 Free article. Review.
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. ...Micronutrients, including vitamins, are potent antioxidants that exert anti-inflammatory effects, and are used in the treatment of NAFLD
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. ...M …
Current and future pharmacological therapies for NAFLD/NASH.
Sumida Y, Yoneda M. Sumida Y, et al. J Gastroenterol. 2018 Mar;53(3):362-376. doi: 10.1007/s00535-017-1415-1. Epub 2017 Dec 16. J Gastroenterol. 2018. PMID: 29247356 Free PMC article. Review.
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and there is no approved pharmacotherapy. The efficacy of vitamin E and pioglitazone has been established in nonalcoholic steatohepatiti …
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and there …
Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials.
Amanullah I, Khan YH, Anwar I, Gulzar A, Mallhi TH, Raja AA. Amanullah I, et al. Postgrad Med J. 2019 Nov;95(1129):601-611. doi: 10.1136/postgradmedj-2018-136364. Epub 2019 Aug 21. Postgrad Med J. 2019. PMID: 31434683 Review.
The efficacy of vitamin E among patients with non-alcoholic fatty liver disease (NAFLD) is unclear. ...Four of the five RCTs on adults demonstrated significant improvements in alanine transaminase and other liver func …
The efficacy of vitamin E among patients with non-alcoholic fatty liver disease (NAFLD
Nonalcoholic fatty liver disease: a systematic review.
Rinella ME. Rinella ME. JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370. JAMA. 2015. PMID: 26057287 Review.
IMPORTANCE: Nonalcoholic fatty liver disease and its subtype nonalcoholic steatohepatitis affect approximately 30% and 5%, respectively, of the US population. ...OBJECTIVES: To illustrate how to identify patients with nonalcoholic fatty liver
IMPORTANCE: Nonalcoholic fatty liver disease and its subtype nonalcoholic steatohepatitis affect approximately 30% and …
Therapies in non-alcoholic steatohepatitis (NASH).
Oseini AM, Sanyal AJ. Oseini AM, et al. Liver Int. 2017 Jan;37 Suppl 1(Suppl 1):97-103. doi: 10.1111/liv.13302. Liver Int. 2017. PMID: 28052626 Free PMC article. Review.
The hallmark of non-alcoholic fatty liver disease (NAFLD) is excessive fatty accumulation in the hepatocytes, which may be an isolated event (non-alcoholic fatty liver, NAFL) or accompanied by evidence o …
The hallmark of non-alcoholic fatty liver disease (NAFLD) is excessive fatty accumulation i …
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Bril F, Biernacki DM, Kalavalapalli S, Lomonaco R, Subbarayan SK, Lai J, Tio F, Suman A, Orsak BK, Hecht J, Cusi K. Bril F, et al. Diabetes Care. 2019 Aug;42(8):1481-1488. doi: 10.2337/dc19-0167. Epub 2019 May 21. Diabetes Care. 2019. PMID: 31332029 Clinical Trial.
Patients with T2DM and biopsy-proven NASH (n = 105) were randomized to vitamin E 400 IU b.i.d., vitamin E 400 IU b.i.d. plus pioglitazone 45 mg/day, or placebo. ...The primary end point was a two-point reduction in the nonalcoholic fatty live
Patients with T2DM and biopsy-proven NASH (n = 105) were randomized to vitamin E 400 IU b.i.d., vitamin E 400 IU …
NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.
Caldwell S. Caldwell S. Clin Mol Hepatol. 2017 Jun;23(2):103-108. doi: 10.3350/cmh.2017.0103. Epub 2017 May 10. Clin Mol Hepatol. 2017. PMID: 28494529 Free PMC article. Review.
Non-alcoholic steatohepatitis (NASH) is the more aggressive form of non-alcoholic fatty liver disease (NAFLD). ...Vitamin E has had some efficacy in pediatric NASH but questionable efficacy in even mild NASH am
Non-alcoholic steatohepatitis (NASH) is the more aggressive form of non-alcoholic fatty liver d
Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis.
Vilar-Gomez E, Vuppalanchi R, Gawrieh S, Ghabril M, Saxena R, Cummings OW, Chalasani N. Vilar-Gomez E, et al. Hepatology. 2020 Feb;71(2):495-509. doi: 10.1002/hep.30368. Epub 2019 Mar 6. Hepatology. 2020. PMID: 30506586
Vitamin E improves liver histology in adults with nonalcoholic steatohepatitis (NASH) but not diabetes, but its impact on long-term patient outcomes is unknown. ...Two hundred and thirty-six patients with biopsy-proven NASH and bridging fibrosis or cirrhosis
Vitamin E improves liver histology in adults with nonalcoholic steatohepatitis (NASH) but not diabetes, but its impact
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Ünalp A, Clark JM, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR; Nonalcoholic Steatohepatitis Clinical Research Network. Lavine JE, et al. JAMA. 2011 Apr 27;305(16):1659-68. doi: 10.1001/jama.2011.520. JAMA. 2011. PMID: 21521847 Free PMC article. Clinical Trial.
CONTEXT: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in US children and adolescents and can present with advanced fibrosis or nonalcoholic steatohepatitis (NASH). No treatment has been established. OB …
CONTEXT: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in US c …
407 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page